High Tower Advisors, LLC Merck & Co., Inc. Call Options Transaction History

High Tower Advisors, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $44,460 - $51,588	400 New	400 $45,000
Q1 2022 May 12, 2022	SELL	$73.51 - $82.4 $146,872 - $164,635	-1,998 Reduced 99.9%	2 $1,000
Q2 2021 Aug 06, 2021	BUY	$70.31 - $77.77 $140,268 - $155,151	1,995 Added 39900.0%	2,000 $6,000
Q4 2020 Feb 10, 2021	SELL	$71.77 - $79.65 $265,190 - $294,306	-3,695 Reduced 99.86%	5 $0
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $256,130 - $290,325	3,500 Added 1750.0%	3,700 $3,000
Q2 2020 Aug 10, 2020	SELL	$70.42 - $80.13 $267,596 - $304,494	-3,800 Reduced 95.0%	200 $1,000
Q2 2018 Aug 14, 2018	BUY	$50.83 - $59.72 $203,320 - $238,880	4,000 New	4,000 $6,000

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.